These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7496341)

  • 1. Delay in corneal allograft rejection due to anti-CD4 antibody given alone and in combination with cyclosporin A and leflunomide.
    Coupland SE; Krause L; Karow AC; Bartlett RR; Lehmann M; Hoffmann F
    Ger J Ophthalmol; 1995 Sep; 4(5):294-301. PubMed ID: 7496341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow-cytometric analysis of peripheral lymphocytes in the rat following penetrating keratoplasty and immunosuppressive treatment.
    Klebe S; Coupland SE; Krause L; Hoffmann F
    Ger J Ophthalmol; 1996 May; 5(3):137-45. PubMed ID: 8803575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leflunomide therapy following penetrating keratoplasty in the rat.
    Coupland SE; Klebe S; Karow AC; Krause L; Kruse H; Bartlett RR; Hoffmann F
    Graefes Arch Clin Exp Ophthalmol; 1994 Oct; 232(10):622-7. PubMed ID: 8001831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misoprostol with cyclosporin A prolongs corneal allograft survival in an animal model.
    Olsen TW; Gothard TW; Holland EJ
    Cornea; 1996 Jan; 15(1):76-81. PubMed ID: 8907385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI; Cofer BR; Davies C; Alexander JW
    Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC; Mainolfi E; Madwed JB
    J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation with anti-alphabeta T-cell receptor monoclonal antibodies in combination with cyclosporine A improves regeneration in nerve allografts.
    Scharpf J; Strome M; Siemionow M
    Microsurgery; 2006; 26(8):599-607. PubMed ID: 17066409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide controls rejection in hamster to rat cardiac xenografts.
    Xiao F; Chong AS; Foster P; Sankary H; McChesney L; Koukoulis G; Yang J; Frieders D; Williams JW
    Transplantation; 1994 Oct; 58(7):828-34. PubMed ID: 7940718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
    Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
    Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model.
    Jia Z; Jiao C; Zhao S; Li X; Ren X; Zhang L; Han ZC; Zhang X
    Exp Eye Res; 2012 Sep; 102():44-9. PubMed ID: 22800963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
    Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
    Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of leflunomide and cyclosporine on graft survival and changes in lymphocyte phenotypes in a rat heart allotransplantation model.
    Johansen A; Jensen JE; Horn HC; Nielsen B; Kemp E
    Transpl Immunol; 1998 Mar; 6(1):48-52. PubMed ID: 9640628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of corneal allograft survival with leflunomide.
    Niederkorn JY; Lang LS; Ross J; Mellon J; Robertson SM
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3783-5. PubMed ID: 8088966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts.
    Lin Y; Vandeputte M; Waer M
    J Immunol; 1998 Jan; 160(1):369-75. PubMed ID: 9551993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic activity of malononitrilamides with cyclosporine to control and reverse xenograft rejection.
    Schorlemmer HU; Kurrle R
    Int J Tissue React; 1997; 19(3-4):149-56. PubMed ID: 9506316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.